These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 10584250
21. Neurocysticercosis: Diagnostic problems & current therapeutic strategies. Rajshekhar V. Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530 [Abstract] [Full Text] [Related]
22. [Neurocysticercosis]. Duchêne M, Benoudiba F, Iffenecker C, Hadj-Rabia M, Caldas J, Doyon D. J Radiol; 1999 Dec; 80(12):1623-7. PubMed ID: 10642655 [Abstract] [Full Text] [Related]
23. [About an autochtonous case of neurocysticercosis in Mali]. Maïga Y, Diallo M, Bouteille B, Konate A, Diarra M, Maïga M, Marjolet M. Bull Soc Pathol Exot; 2009 Oct; 102(4):211-4. PubMed ID: 19950534 [Abstract] [Full Text] [Related]
26. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Sotelo J, Jung H. Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011 [Abstract] [Full Text] [Related]
27. Medical management of neurocysticercosis. Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL. Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143 [Abstract] [Full Text] [Related]
28. [A Histopathologically Diagnosed Neurocysticercosis Case from Türkiye]. Özer Balin Ş, Enez M, Akbulut A, Çalık M, Akgün B, Balgetir F, Yıldırım H. Mikrobiyol Bul; 2022 Oct; 56(4):755-762. PubMed ID: 36458721 [Abstract] [Full Text] [Related]
29. Epidemiology of neurocysticercosis and epilepsy, is everything described? Tellez-Zenteno JF, Hernandez-Ronquillo L. Epilepsy Behav; 2017 Nov; 76():146-150. PubMed ID: 28526213 [Abstract] [Full Text] [Related]
31. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? Romo ML, Carpio A, Kelvin EA. J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292 [Abstract] [Full Text] [Related]
32. [Neurocysticercosis: report of three cases and recommendations of treatment]. Alvarez Rodríguez E, Torres-Gárate R, Gutiérrez Larráinzar A, Cabello J, Espinós Pérez D. An Med Interna; 2004 Aug; 21(8):382-6. PubMed ID: 15373721 [Abstract] [Full Text] [Related]
34. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report]. Sanchez-Larsen A, Monteagudo M, Lozano-Setien E, Garcia-Garcia J. Rev Argent Microbiol; 2015 Jan; 47(3):201-5. PubMed ID: 26321177 [Abstract] [Full Text] [Related]
35. Current approaches to cysticidal drug therapy for neurocysticercosis. Del Brutto OH. Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507 [Abstract] [Full Text] [Related]
36. [Clinical manifestations of neurocysticercosis]. San-juan Orta D. Neurologia; 2009 Jun; 24(5):331-5. PubMed ID: 19642036 [Abstract] [Full Text] [Related]
37. Neurocysticercosis: the enigmatic disease. Agapejev S. Cent Nerv Syst Agents Med Chem; 2011 Dec 01; 11(4):261-84. PubMed ID: 22300228 [Abstract] [Full Text] [Related]
39. Cysticercosis and epilepsy: a critical review. Carpio A, Escobar A, Hauser WA. Epilepsia; 1998 Oct 01; 39(10):1025-40. PubMed ID: 9776322 [Abstract] [Full Text] [Related]
40. [Update in neurocysticercosis treatment]. Pérez-López C, Isla-Guerrero A, Alvarez F, Budke M, Fernández-Miranda JC, Paz JF, Pérez-Alvarez M. Rev Neurol; 1998 Oct 01; 36(9):805-11. PubMed ID: 12717665 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]